
Lightspeed Microscopy Inc Profile last edited on: 9/20/2021
CAGE: 8BCQ7
UEI: DVN2AF9A1YV3
Business Identifier: End-to-end 3D pathology platform accelerating drug development and improving clinical diagnostics. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 07
County: King
Congr. District: 07
County: King
Public Profile
Lightspeed Microscopy is addressing the acceleration of drug development and improved clinical diagnostics by transforming the field of pathology from 2D and slide-based to 3D and digital. The firm has a full stack solution with proprietary sample preparation, patented open-top light-sheet microscopy, and cloud-based data processing, visualization, and AI analysis. LightsSpeeds unique open-top light-sheet microscope design enables fast, non-destructive, 3D microscopy of large and/or multiple tissue specimens. Various pharma companies are already using Lightspeed's 3D pathology product to accelerate their pre-clinical drug development through better understanding of mechanisms of action and biodistribution of their lead compounds.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2024 | 2 | NIH | $1,392,112 | |
Project Title: Open-top light-sheet microscopy for non-destructive 3D pathology of prostate biopsies | ||||
2021 | 1 | NIH | $269,351 | |
Project Title: 3D quantification of NASH-related liver fibrosis using open-top light-sheet microscopy | ||||
2021 | 1 | NIH | $398,305 | |
Project Title: Same-day Breast Pathology Results using Open-Top Light-Sheet Microscopy for Image-guided Core Needle Biopsies |
Key People / Management
Nicholas Reder -- Co-Founder and CEO
Chris Brewer
Steve Buckley -- Former CEO
Adam Glaser -- Co-Founder
Jonathan Liu -- Co-Founder
Caleb Stoltzfus -- Principal Engineer
Larry True -- Co-Founder
Chris Brewer
Steve Buckley -- Former CEO
Adam Glaser -- Co-Founder
Jonathan Liu -- Co-Founder
Caleb Stoltzfus -- Principal Engineer
Larry True -- Co-Founder
Company News
There are no news available.